concentrated and further purified by size exclusion chromatography on a Superdex 200 26/60 column (GE Healthcare) equilibrated in 20 mM Tris pH 8.0, 150 mM NaCl, 0.5 mM TCEP. Protein identity and integrity was confirmed by electrospray mass spectrometry. GSTfusion protein production, LB medium was inoculated 1:50 with an overnight culture of E. coli transformed with GST-PIH1D1 wt or K64A and grown to OD 0.6-1.0. The expression was with 0.1 mM IPTG for 2 hours at 37 o C. Cells were pelleted by centrifugation at 3,000 x g for 15 mins at 4 o C. The pellets were resuspended in 30ml of cold PBS (140 mM NaCl, 2.7 M KCl, 10mM Na 2 HPO 4 , 1.8mM KH 2 PO 4 , pH 7.3) supplemented with protease inhibitor cocktail (Roche), and lysed by sonication. The samples were centrifuged for 2 x 10min at 30 000 x g and incubated with 1.33ml of glutathione Sepharose 4 Fast Flow beads (GE Healthcare),
washed 3 x with PBS prior adding to the samples. The beads were washed 3 x with 10 ml of PBS and eluted with 3 x 1 ml aliquots of glutathionine buffer (50 mM Tris pH 8.0, 10 mM reduced glutathionine) and dialysed over night against Tris buffer (50 mM Tris pH 8.0, 150 mM NaCl, 1 mM EDTA, 2.5 mM EGTA, 10% v/v glycerol).
Mass spectrometry analysis and protein identification
SYPRO ruby-stained polyacrylamide gel slices (1-2 mm) were excised using a scalpel and processed for mass spectrometry using the Janus automated liquid handling system (PerkinElmer, U.K.). Briefly, the excised protein gel pieces were placed in individual wells of a 96-well microtitre plate and destained with 50 % vol/vol acetonitrile and 50 mM ammonium bicarbonate, reduced with 10 mM DTT, and alkylated with 55 mM iodoacetamide. After alkylation, proteins in gel pieces were digestedwith 6 ng/µl trypsin overnight at 37 °C. The resulting peptides were extracted in 1% v/v formic acid, 2 % v/v acetonitrile. 
Plasmids
pDEST-GST PIH1D1 wt was previously described (4). All mutations were introduced using the QuickChange II site-directed mutagenesis kit (Stratagene). For mammalian cell expression the PIH1D1 constructs were cloned by Gateway LR reaction to pDEST-FTF/FRT/TO. cDNAs for SNRP116, UBR5, ECD and RPAP3 were purchased from Origene and cloned to pDONR221 (Invitrogen), from which they were cloned by Gateway LR reaction to pDEST-FTF/FRT/TO plasmid. pDEST LXSN-Flag was created from pLXSN by insertion of Gateway cassette and Flag sequence into the multiple cloning site.
Protein extracts, Immunoprecipation, λ phosphatase treatment and peptide pull-down
For whole cell extracts, the cells were solubilized on ice in lysis buffer (50 mM Tris-HCL pH 8, 150 mM NaCl, 1 % Triton X-100, 1 mM EDTA, 2. 
Antibodies
The anti-phospho TEL2 antibody was reported previously (4). TEL2 (HCLK2) antibody has been described previously (5, 6) . Antibodies against ATM (ab91, rabbit polyclonal), PIH1D1
(ab57512, mouse monoclonal), HSP90 (ab13492, mouse monoclonal), GST (ab6613, goat polyclonal), RUVBL1 (ab51500, mouse monoclonal and ab75826, rabbit polyclonal) and RUVBL2 (ab36569, rabbit polyclonal), UBR5 (EDD, ab4376, goat polyclonal), actin (ab8226, mouse monoclonal), ECD (hSGT1, ab99293, rabbit polyclonal) and SNRP116 (EFTUD2, ab72456) were purchased from Abcam. Antibody against RPAP3 (WH0079657M1, mouse monoclonal anti-FLJ21908), and antiFlag M2-peroxidase conjugate (A 8592, mouse monoclonal) were purchased from Sigma. RPB1 antibody (N20, sc-899) and p53 (FL-393, sc-6243) were purchased from Santa Cruz Biotechnology, p53 pS15 (#9284, rabbit polyclonal) and p53 (#9282, rabbit polyclonal) were purchased from Cell Signaling
Technology and from BD Biosciences, respectively. Tables   Table S1, 
Supplemental

